Dr. Anish Meerasahib, M.D.
What this data tells you about Dr. Meerasahib
Dr. Anish Meerasahib is a hematology & oncology in Webster, TX, with 17 years in practice. Based on federal Medicare data, Dr. Meerasahib performed 93,974 Medicare services across 2,861 unique beneficiaries.
Between the years covered by Open Payments, Dr. Meerasahib received a total of $5,819 from 43 pharmaceutical and/or device companies across 146 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Meerasahib is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 31,110 | $0 | $5 |
| Anti-nausea injection (fosaprepitant) | 16,050 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 9,700 | $43 | $137 |
| Darbepoetin injection (Aranesp) for anemia | 7,125 | $2 | $20 |
| Iron sucrose injection (Venofer) | 6,000 | $0 | $2 |
| Paclitaxel chemotherapy injection | 5,710 | $0 | $8 |
| Contrast dye for imaging (iodine-based) | 4,855 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 1,980 | $19 | $67 |
| Dexamethasone injection (steroid) | 1,905 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,430 | $1 | $114 |
| Injection, leucovorin calcium, per 50 mg | 945 | $3 | $25 |
| Blood draw (venipuncture) | 900 | $8 | $20 |
| Complete blood count (CBC) with differential | 855 | $8 | $36 |
| Comprehensive metabolic blood panel | 777 | $10 | $64 |
| Injection, fluorouracil, 500 mg | 621 | $2 | $13 |
| Office visit, established patient (30-39 min) | 596 | $98 | $368 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 441 | $23 | $157 |
| Injection, granisetron hydrochloride, 100 mcg | 325 | $0 | $24 |
| Administration of chemotherapy into vein, 1 hour or less | 261 | $105 | $707 |
| Injection, carboplatin, 50 mg | 228 | $2 | $300 |
| Injection of additional new drug or substance into vein | 207 | $12 | $108 |
| Administration of chemotherapy into vein, each additional hour | 150 | $22 | $161 |
| Administration of additional new drug or substance into vein, 1 hour or less | 133 | $52 | $344 |
| Office visit, established patient (20-29 min) | 133 | $61 | $250 |
| Drug injection, under skin or into muscle | 132 | $11 | $96 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 125 | $51 | $313 |
| Injection, zoledronic acid, 1 mg | 122 | $7 | $431 |
| Lactate dehydrogenase (enzyme) level | 97 | $6 | $31 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 91 | $91 | $657 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 90 | $1,185 | $4,802 |
| Injection, diphenhydramine hcl, up to 50 mg | 89 | $1 | $7 |
| Reticulated (young) platelet measurement | 64 | $35 | $143 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 63 | $16 | $94 |
| New patient office visit, complex (60-74 min) | 63 | $174 | $709 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 60 | $134 | $500 |
| Administration of additional new drug or substance into vein using push technique | 54 | $45 | $289 |
| Red blood count, automated test | 51 | $4 | $23 |
| Hospital follow-up visit, high complexity | 51 | $93 | $357 |
| Ct scan of chest with contrast | 47 | $52 | $821 |
| Hospital follow-up visit, moderate complexity | 47 | $60 | $247 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 44 | $59 | $211 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 42 | $23 | $145 |
| CT scan of abdomen and pelvis with contrast | 40 | $181 | $1,067 |
| Unclassified drugs | 38 | $1 | $8 |
| Uric acid level test | 33 | $4 | $25 |
| Initial hospital admission, high complexity | 33 | $139 | $694 |
| New patient office visit (45-59 min) | 21 | $105 | $565 |
| Infusion, normal saline solution , 1000 cc | 21 | $2 | $19 |
| CT scan of chest, without contrast | 19 | $50 | $686 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (50%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Meerasahib is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), and mixed engagement industry engagement, with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Meerasahib experienced with iron infusion (feraheme)?
Does Dr. Meerasahib receive payments from pharmaceutical companies?
How do Dr. Meerasahib's costs compare to other hematology & oncologys in Webster?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology